We’re excited for this latest round of funding from @NSFSBIR as we expand our portfolio of vascularized platforms for our clients. #smallbusiness #drugdevelopment
Replying to @AracariBio
@AracariBio announces a Phase II #SBIR award from the @NSF to commercialize its proprietary Vasoreactive Vascularized Micro-Organ (VMO-VA) platform. 👩🔬👨🔬
biospace.com/article/release…
#medtech #lifescience #socal
Thanks to @OctaneOC for a great evening highlighting Orange County’s High Tech Innovators! We’re honored to be a finalist alongside so many other accomplished start-ups! @ulpirvine
We're looking forward to attending the Octane Awards tonight with our fellow Innovation Finalists! @OctaneOC
#DYK Aracari's VMT™ platform facilitates the measurement of tumor killing #drugdiscovery #organonachip
#DYK Aracari's VMT™ gives our clients the ability to study the efficacy of anti-angiogenic compounds #drugdiscovery #organonachip
#DYK Aracari's VMT™ allows our clients to test for donor to donor variation #drugdiscovery #organonachip
#DYK Aracari's VMO™ and VMO™ can directly assess tissue inflammation and toxicity
#DYK Aracari's VMT™ platform can improve the #drugdiscovery process
Amazing video from our collaborators @HughesLabUCI showing co-development of blood vessels and human micro-tumors!
Replying to @sciencefocus
This time-lapse video shows a human micro-tumour growing over 10 days in a lab. 🤯
The tumour, in blue, grows with the support of vessels, shown in red.
Dr Stephanie Hachey and Dr Christopher Hughes were awarded second place for their video. @NikonSmallWorld @HughesLabUCI
Read about how Aracari CSO, Chris Hughes and Aracari Co-Founder, Steve George, create vascularized organoids in their recently published paper here: tinyurl.com/5whfdb5p #organonachip
Read about how Aracari's VMT™ platform accurately recapitulates native biology in this recently published paper by Aracari CSO, Chris Hughes, and Aracari Co-Founder, Steve George! #organonachip tinyurl.com/jd3e66f4
#DYK Aracari's VMO™ accurately shows vascular toxicity and damage in the presence of PBMCs and proprietary compounds. #drugdiscovery
Aracari Biosciences is proud to be a finalist of the 2021 Octane Outstanding Innovation in Medical Technology/Life Sciences Award for our human vascularized micro-organ (VMO™)!
#DYK Aracari's VMO™ platform accurately predicts how drug compounds may damage blood vessels
#DYK Aracari's platform contains perfusable blood vessels #organonachip
Catch @thesugarscience’s Ask the Expert Online Event on Thursday, 7/15 at 12–1pm PT with Aracari CSO Chris Hughes & Lead Scientist Hugh Bender where they’ll be discussing new research using our human vascularized micro-organ (VMO™) to model diabetes! tinyurl.com/bs7p4mwd
This Post is from an account that no longer exists. Learn more
Aracari Biosciences is a proud sponsor of the 3rd Annual Cell Engager Summit | 2021 Virtual Event. Find out more at cell-engager-summit.com #drugdiscovery
Catch Chris Hughes, Aracari CSO, on his talk on The Promise of Vascularized Micro-Organs & Tumors for Drug Discovery at the Cell Engager Summit 2021 today, June 29th at 12:30pm ET! #drugdiscovery Find out more at cell-engager-summit.com
We're proud to be an Exhibitor Sponsor at the first @MPSWorldSummit. Lots to learn about how regulatory acceptance of these new #tissuechip platforms can advance #drugdiscovery



















